Roche Seeks ‘Targeted Acquisitions,’ Not Abbott-Sized Deal
By Naomi Kresge - Oct 21, 2011 5:51 AM CT
Roche Holding AG (ROG) will continue to pursue a strategy of “targeted acquisitions” to complement its existing portfolio and isn’t seeking a mega-merger, Chief Executive Officer Severin Schwan said today.
“We’ve focused on smaller, bolt-on acquisitions,” Schwan said in an interview in Frankfurt after being asked whether an acquisition of a portion of Abbott Laboratories (ABT)’ business is attractive. “That’s how I see us continuing in our M&A strategy. We are not interested in mega-mergers. We are interested in very targeted acquisitions which complement our technologies and portfolios.”